EE197 The Impact of Funding Tocilizumab for the Inpatient Treatment of COVID-19 in the United States: A Distributional Cost-Effectiveness Analysis
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.496
https://www.valueinhealthjournal.com/article/S1098-3015(24)00611-9/fulltext
Section Title :
Section Order :
11834
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00611-9&doi=10.1016/j.jval.2024.03.496